Antiviral Drug Remdesivir Approved as COVID-19 Treatment by FDA

Headline Roundup October 23rd, 2020

The Food and Drug Administration (FDA) approved remdesivir, an antiviral drug from Gilead Sciences, as a treatment for COVID-19 Thursday. The drug, sold under the name Veklury, will be used for hospitalized COVID-19 patients. Previously authorized by the FDA for emergency use to treat COVID-19, it has become the first FDA-approved treatment for the virus. Typically administered in five doses through an IV, remdesivir has shown to shorten recovery time by working to stop replication of SARS-CoV-2, the virus that causes COVID-19. However, a World Health Organization (WHO) study has found that four drugs, including remdesivir, have no effect in curing the virus. President Donald Trump was administered remdesivir along with several other drugs during his bout with the virus earlier this month.

The news has been covered similarly by outlets from across the political spectrum.

Antiviral Drug Remdesivir Approved as COVID-19 Treatment by FDA

From the Left
13320

The Food and Drug Administration (FDA) on Thursday approved remdesivir for the treatment of hospitalized COVID-19 patients.

The antiviral treatment, which is made by Gilead Sciences and sold as Veklury, was used to treat President Donald Trump after he contracted the virus earlier this month.

Remdesivir previously received emergency use authorization from the FDA in May for patients with severe cases of COVID-19. The agency later expanded its emergency use authorization in August to include patients who were hospitalized as a result of their COVID-19 infections.

Read full story
From the Right
13320

The Food and Drug Administration granted approval of remdesivir, an antiviral drug from Gilead Sciences and a treatment for COVID-19.

The drug, sold under the name Veklury, will be used for hospitalized COVID-19 patients, Gilead said. It is the first coronavirus disease treatment to receive FDA approval.

“The approval of Veklury marks an important milestone in efforts to help address the pandemic by offering an effective treatment that helps patients recover faster and, in turn, helps preserve scarce healthcare resources,” said Dr. Barry Zingman, a professor at the Albert Einstein...

Read full story
From the Center
13320

The Food and Drug Administration (FDA) on Thursday approved the antiviral drug remdesivir as a treatment for patients with COVID-19 who require hospitalization.

Given through an IV, remdesivir works to stop replication of SARS-CoV-2, the virus that causes COVID-19, according to the drug's manufacturer, California-based Gilead Sciences, Inc. Previously authorized by the FDA for emergency use to treat COVID-19, the drug is now the first and only approved COVID-19 treatment in the United States, Gilead said in a release.

“Since the beginning of the COVID-19 pandemic, Gilead has worked relentlessly...

Read full story

Try the New AllSides Mobile App

The only news app you’ll ever need. Now available on iOS. Android version coming soon.